✦ LIBER ✦

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

✍ Scribed by Bertolotto, Antonio; Capobianco, Marco; Amato, Maria Pia; Capello, Elisabetta; Capra, Ruggero; Centonze, Diego; Ioia, Maria; Gallo, Antonio; Grimaldi, Luigi; Imberti, Luisa; Lugaresi, Alessandra; Mancinelli, Chiara; Marrosu, Maria Giovanna; Moiola, Lucia; Montanari, Enrico; Romano, Silvia; Musu, Luigina; Paolicelli, Damiano; Patti, Francesco; Pozzilli, Carlo; Rossi, Silvia; Salvetti, Marco; Tedeschi, Gioachino; Tola, Maria Rosaria; Troiano, Maria; Zaffaroni, Mauro; Malucchi, Simona

Book ID: 121562442
Publisher: Springer Milan
Year: 2013
Tongue: English
Weight: 255 KB
Volume: 35
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-013-1616-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Guidelines on the clinical u

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

✍ Bertolotto, Antonio; Capobianco, Marco; Amato, Maria Pia; Capello, Elisabetta; C 📂 Article 📅 2014 🏛 Springer Milan 🌐 English ⚖ 117 KB

Guidelines on use of anti-IFN-β antibody

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

✍ P. S. Sørensen; F. Deisenhammer; P. Duda; R. Hohlfeld; K.-M. Myhr; J. Palace; C. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Recommendations for clinical use of data

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

✍ Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Hans 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 206 KB

Further study on the specificity and inc

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

A case study on the effect of neutralizi

A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging

✍ A. W. Chiu; M. Ehrmantraut; N. D. Richert; V. N. Ikonomidou; S. Pellegrini; H. F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB